Found 61 matching trials
SAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profiles in Metastatic NSCLC Patients PHASE2 Open label multicentric randomized phase II trial, using high throughput ge...
Show More Location
Centre Hospitalier Henri Duffau
Learn More & Join Trial
Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer PHASE1 This pilot phase I trial studies whether it is feasible to conduct a detail...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Olaparib, Durvalumab, and Tremelimumab in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube or Primary Peritoneal Cancer With BRCA1 or BRCA2 Mutation PHASE2 This phase I/II trial studies the side effects and best dose of olaparib wh...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Phase I Study of AZD5363 + Olaparib + Durvalumab in Patients With Advanced or Metastatic Solid Tumor Malignancies PHASE1 This is a Phase 1 dose-escalation study to evaluate the safety and tolerabi...
Show More Location
National University Hospital
Learn More & Join Trial
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer PHASE1 This phase I trial tests the safety and tolerability of olaparib in combina...
Show More Status
Active Not Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Learn More & Join Trial
NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study PHASE2 The goal of this phase 2 clinical trial is to learn if the three treatments...
Show More Location
Multiple Locations
Learn More & Join Trial
Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients PHASE3 This is a Phase III randomised, double-blind, multi-centre study to evaluat...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA) PHASE2 This is a randomized, international, multicenter, Phase II study designed t...
Show More Learn More & Join Trial
A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. PHASE1 The purpose of this study is to look at the effectiveness, safety, and anti...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Durvalumab and Olaparib in Metastatic or Recurrent Endometrial Cancer PHASE2 The DOMEC trial is designed as a Dutch Gynecological Oncology Group (DGOG),...
Show More Location
Amsterdam UMC, AMC
Learn More & Join Trial